Global Measles and Rubella Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Measles and Rubella Vaccines Industry Forecast” looks at past sales and reviews total world Measles and Rubella Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Measles and Rubella Vaccines sales for 2023 through 2029. With Measles and Rubella Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles and Rubella Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Measles and Rubella Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles and Rubella Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Measles and Rubella Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles and Rubella Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles and Rubella Vaccines.
The global Measles and Rubella Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Measles and Rubella Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Measles and Rubella Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Measles and Rubella Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Measles and Rubella Vaccines players cover Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc. and Takeda Pharmaceutical Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Measles and Rubella Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Measles and Rubella Vaccines market?
What factors are driving Measles and Rubella Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Measles and Rubella Vaccines market opportunities vary by end market size?
How does Measles and Rubella Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Measles and Rubella Vaccines Industry Forecast” looks at past sales and reviews total world Measles and Rubella Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Measles and Rubella Vaccines sales for 2023 through 2029. With Measles and Rubella Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles and Rubella Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Measles and Rubella Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles and Rubella Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Measles and Rubella Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles and Rubella Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles and Rubella Vaccines.
The global Measles and Rubella Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Measles and Rubella Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Measles and Rubella Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Measles and Rubella Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Measles and Rubella Vaccines players cover Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc. and Takeda Pharmaceutical Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Measles and Rubella Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Monovalent Vaccines
- Multivalent Vaccines
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Serum Institute of India Ltd.
- Merck & Co. Inc.
- GlaxoSmithKline Inc.
- Takeda Pharmaceutical Company
What is the 10-year outlook for the global Measles and Rubella Vaccines market?
What factors are driving Measles and Rubella Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Measles and Rubella Vaccines market opportunities vary by end market size?
How does Measles and Rubella Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Measles and Rubella Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Measles and Rubella Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Measles and Rubella Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Measles and Rubella Vaccines Segment by Type
2.2.1 Monovalent Vaccines
2.2.2 Multivalent Vaccines
2.3 Measles and Rubella Vaccines Sales by Type
2.3.1 Global Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Measles and Rubella Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Measles and Rubella Vaccines Sale Price by Type (2018-2023)
2.4 Measles and Rubella Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Measles and Rubella Vaccines Sales by Application
2.5.1 Global Measles and Rubella Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Measles and Rubella Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Measles and Rubella Vaccines Sale Price by Application (2018-2023)
3 GLOBAL MEASLES AND RUBELLA VACCINES BY COMPANY
3.1 Global Measles and Rubella Vaccines Breakdown Data by Company
3.1.1 Global Measles and Rubella Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Measles and Rubella Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Measles and Rubella Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Measles and Rubella Vaccines Revenue by Company (2018-2023)
3.2.2 Global Measles and Rubella Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Measles and Rubella Vaccines Sale Price by Company
3.4 Key Manufacturers Measles and Rubella Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Measles and Rubella Vaccines Product Location Distribution
3.4.2 Players Measles and Rubella Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MEASLES AND RUBELLA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Measles and Rubella Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Measles and Rubella Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Measles and Rubella Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Measles and Rubella Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Measles and Rubella Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Measles and Rubella Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Measles and Rubella Vaccines Sales Growth
4.4 APAC Measles and Rubella Vaccines Sales Growth
4.5 Europe Measles and Rubella Vaccines Sales Growth
4.6 Middle East & Africa Measles and Rubella Vaccines Sales Growth
5 AMERICAS
5.1 Americas Measles and Rubella Vaccines Sales by Country
5.1.1 Americas Measles and Rubella Vaccines Sales by Country (2018-2023)
5.1.2 Americas Measles and Rubella Vaccines Revenue by Country (2018-2023)
5.2 Americas Measles and Rubella Vaccines Sales by Type
5.3 Americas Measles and Rubella Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Measles and Rubella Vaccines Sales by Region
6.1.1 APAC Measles and Rubella Vaccines Sales by Region (2018-2023)
6.1.2 APAC Measles and Rubella Vaccines Revenue by Region (2018-2023)
6.2 APAC Measles and Rubella Vaccines Sales by Type
6.3 APAC Measles and Rubella Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Measles and Rubella Vaccines by Country
7.1.1 Europe Measles and Rubella Vaccines Sales by Country (2018-2023)
7.1.2 Europe Measles and Rubella Vaccines Revenue by Country (2018-2023)
7.2 Europe Measles and Rubella Vaccines Sales by Type
7.3 Europe Measles and Rubella Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Measles and Rubella Vaccines by Country
8.1.1 Middle East & Africa Measles and Rubella Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Measles and Rubella Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Measles and Rubella Vaccines Sales by Type
8.3 Middle East & Africa Measles and Rubella Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Measles and Rubella Vaccines
10.3 Manufacturing Process Analysis of Measles and Rubella Vaccines
10.4 Industry Chain Structure of Measles and Rubella Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Measles and Rubella Vaccines Distributors
11.3 Measles and Rubella Vaccines Customer
12 WORLD FORECAST REVIEW FOR MEASLES AND RUBELLA VACCINES BY GEOGRAPHIC REGION
12.1 Global Measles and Rubella Vaccines Market Size Forecast by Region
12.1.1 Global Measles and Rubella Vaccines Forecast by Region (2024-2029)
12.1.2 Global Measles and Rubella Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Measles and Rubella Vaccines Forecast by Type
12.7 Global Measles and Rubella Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Serum Institute of India Ltd.
13.1.1 Serum Institute of India Ltd. Company Information
13.1.2 Serum Institute of India Ltd. Measles and Rubella Vaccines Product Portfolios and Specifications
13.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Serum Institute of India Ltd. Main Business Overview
13.1.5 Serum Institute of India Ltd. Latest Developments
13.2 Merck & Co. Inc.
13.2.1 Merck & Co. Inc. Company Information
13.2.2 Merck & Co. Inc. Measles and Rubella Vaccines Product Portfolios and Specifications
13.2.3 Merck & Co. Inc. Measles and Rubella Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co. Inc. Main Business Overview
13.2.5 Merck & Co. Inc. Latest Developments
13.3 GlaxoSmithKline Inc.
13.3.1 GlaxoSmithKline Inc. Company Information
13.3.2 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Inc. Main Business Overview
13.3.5 GlaxoSmithKline Inc. Latest Developments
13.4 Takeda Pharmaceutical Company
13.4.1 Takeda Pharmaceutical Company Company Information
13.4.2 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Portfolios and Specifications
13.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Takeda Pharmaceutical Company Main Business Overview
13.4.5 Takeda Pharmaceutical Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Measles and Rubella Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Measles and Rubella Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Measles and Rubella Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Measles and Rubella Vaccines Segment by Type
2.2.1 Monovalent Vaccines
2.2.2 Multivalent Vaccines
2.3 Measles and Rubella Vaccines Sales by Type
2.3.1 Global Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Measles and Rubella Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Measles and Rubella Vaccines Sale Price by Type (2018-2023)
2.4 Measles and Rubella Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Measles and Rubella Vaccines Sales by Application
2.5.1 Global Measles and Rubella Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Measles and Rubella Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Measles and Rubella Vaccines Sale Price by Application (2018-2023)
3 GLOBAL MEASLES AND RUBELLA VACCINES BY COMPANY
3.1 Global Measles and Rubella Vaccines Breakdown Data by Company
3.1.1 Global Measles and Rubella Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Measles and Rubella Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Measles and Rubella Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Measles and Rubella Vaccines Revenue by Company (2018-2023)
3.2.2 Global Measles and Rubella Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Measles and Rubella Vaccines Sale Price by Company
3.4 Key Manufacturers Measles and Rubella Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Measles and Rubella Vaccines Product Location Distribution
3.4.2 Players Measles and Rubella Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MEASLES AND RUBELLA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Measles and Rubella Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Measles and Rubella Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Measles and Rubella Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Measles and Rubella Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Measles and Rubella Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Measles and Rubella Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Measles and Rubella Vaccines Sales Growth
4.4 APAC Measles and Rubella Vaccines Sales Growth
4.5 Europe Measles and Rubella Vaccines Sales Growth
4.6 Middle East & Africa Measles and Rubella Vaccines Sales Growth
5 AMERICAS
5.1 Americas Measles and Rubella Vaccines Sales by Country
5.1.1 Americas Measles and Rubella Vaccines Sales by Country (2018-2023)
5.1.2 Americas Measles and Rubella Vaccines Revenue by Country (2018-2023)
5.2 Americas Measles and Rubella Vaccines Sales by Type
5.3 Americas Measles and Rubella Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Measles and Rubella Vaccines Sales by Region
6.1.1 APAC Measles and Rubella Vaccines Sales by Region (2018-2023)
6.1.2 APAC Measles and Rubella Vaccines Revenue by Region (2018-2023)
6.2 APAC Measles and Rubella Vaccines Sales by Type
6.3 APAC Measles and Rubella Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Measles and Rubella Vaccines by Country
7.1.1 Europe Measles and Rubella Vaccines Sales by Country (2018-2023)
7.1.2 Europe Measles and Rubella Vaccines Revenue by Country (2018-2023)
7.2 Europe Measles and Rubella Vaccines Sales by Type
7.3 Europe Measles and Rubella Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Measles and Rubella Vaccines by Country
8.1.1 Middle East & Africa Measles and Rubella Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Measles and Rubella Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Measles and Rubella Vaccines Sales by Type
8.3 Middle East & Africa Measles and Rubella Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Measles and Rubella Vaccines
10.3 Manufacturing Process Analysis of Measles and Rubella Vaccines
10.4 Industry Chain Structure of Measles and Rubella Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Measles and Rubella Vaccines Distributors
11.3 Measles and Rubella Vaccines Customer
12 WORLD FORECAST REVIEW FOR MEASLES AND RUBELLA VACCINES BY GEOGRAPHIC REGION
12.1 Global Measles and Rubella Vaccines Market Size Forecast by Region
12.1.1 Global Measles and Rubella Vaccines Forecast by Region (2024-2029)
12.1.2 Global Measles and Rubella Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Measles and Rubella Vaccines Forecast by Type
12.7 Global Measles and Rubella Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Serum Institute of India Ltd.
13.1.1 Serum Institute of India Ltd. Company Information
13.1.2 Serum Institute of India Ltd. Measles and Rubella Vaccines Product Portfolios and Specifications
13.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Serum Institute of India Ltd. Main Business Overview
13.1.5 Serum Institute of India Ltd. Latest Developments
13.2 Merck & Co. Inc.
13.2.1 Merck & Co. Inc. Company Information
13.2.2 Merck & Co. Inc. Measles and Rubella Vaccines Product Portfolios and Specifications
13.2.3 Merck & Co. Inc. Measles and Rubella Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co. Inc. Main Business Overview
13.2.5 Merck & Co. Inc. Latest Developments
13.3 GlaxoSmithKline Inc.
13.3.1 GlaxoSmithKline Inc. Company Information
13.3.2 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Inc. Main Business Overview
13.3.5 GlaxoSmithKline Inc. Latest Developments
13.4 Takeda Pharmaceutical Company
13.4.1 Takeda Pharmaceutical Company Company Information
13.4.2 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Portfolios and Specifications
13.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Takeda Pharmaceutical Company Main Business Overview
13.4.5 Takeda Pharmaceutical Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Measles and Rubella Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Measles and Rubella Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monovalent Vaccines
Table 4. Major Players of Multivalent Vaccines
Table 5. Global Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 6. Global Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Measles and Rubella Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Measles and Rubella Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Measles and Rubella Vaccines Sale Price by Type (2018-2023) & (US$/Dose)
Table 10. Global Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 11. Global Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Measles and Rubella Vaccines Revenue by Application (2018-2023)
Table 13. Global Measles and Rubella Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Measles and Rubella Vaccines Sale Price by Application (2018-2023) & (US$/Dose)
Table 15. Global Measles and Rubella Vaccines Sales by Company (2018-2023) & (K Doses)
Table 16. Global Measles and Rubella Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Measles and Rubella Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Measles and Rubella Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Measles and Rubella Vaccines Sale Price by Company (2018-2023) & (US$/Dose)
Table 20. Key Manufacturers Measles and Rubella Vaccines Producing Area Distribution and Sales Area
Table 21. Players Measles and Rubella Vaccines Products Offered
Table 22. Measles and Rubella Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Measles and Rubella Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Measles and Rubella Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Measles and Rubella Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Measles and Rubella Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Measles and Rubella Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Measles and Rubella Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Measles and Rubella Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Measles and Rubella Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Measles and Rubella Vaccines Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Measles and Rubella Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Measles and Rubella Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Measles and Rubella Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Measles and Rubella Vaccines Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Measles and Rubella Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Measles and Rubella Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Measles and Rubella Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Measles and Rubella Vaccines Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Measles and Rubella Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Measles and Rubella Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Measles and Rubella Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Measles and Rubella Vaccines Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Measles and Rubella Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Measles and Rubella Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Measles and Rubella Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Measles and Rubella Vaccines
Table 58. Key Market Challenges & Risks of Measles and Rubella Vaccines
Table 59. Key Industry Trends of Measles and Rubella Vaccines
Table 60. Measles and Rubella Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Measles and Rubella Vaccines Distributors List
Table 63. Measles and Rubella Vaccines Customer List
Table 64. Global Measles and Rubella Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Measles and Rubella Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Measles and Rubella Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Measles and Rubella Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Measles and Rubella Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Measles and Rubella Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Measles and Rubella Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Measles and Rubella Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Measles and Rubella Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Measles and Rubella Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Measles and Rubella Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Measles and Rubella Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Measles and Rubella Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Measles and Rubella Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Serum Institute of India Ltd. Basic Information, Measles and Rubella Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Serum Institute of India Ltd. Measles and Rubella Vaccines Product Portfolios and Specifications
Table 80. Serum Institute of India Ltd. Measles and Rubella Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 81. Serum Institute of India Ltd. Main Business
Table 82. Serum Institute of India Ltd. Latest Developments
Table 83. Merck & Co. Inc. Basic Information, Measles and Rubella Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck & Co. Inc. Measles and Rubella Vaccines Product Portfolios and Specifications
Table 85. Merck & Co. Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 86. Merck & Co. Inc. Main Business
Table 87. Merck & Co. Inc. Latest Developments
Table 88. GlaxoSmithKline Inc. Basic Information, Measles and Rubella Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Portfolios and Specifications
Table 90. GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 91. GlaxoSmithKline Inc. Main Business
Table 92. GlaxoSmithKline Inc. Latest Developments
Table 93. Takeda Pharmaceutical Company Basic Information, Measles and Rubella Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Portfolios and Specifications
Table 95. Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 96. Takeda Pharmaceutical Company Main Business
Table 97. Takeda Pharmaceutical Company Latest Developments
Table 1. Measles and Rubella Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Measles and Rubella Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monovalent Vaccines
Table 4. Major Players of Multivalent Vaccines
Table 5. Global Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 6. Global Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Measles and Rubella Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Measles and Rubella Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Measles and Rubella Vaccines Sale Price by Type (2018-2023) & (US$/Dose)
Table 10. Global Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 11. Global Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Measles and Rubella Vaccines Revenue by Application (2018-2023)
Table 13. Global Measles and Rubella Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Measles and Rubella Vaccines Sale Price by Application (2018-2023) & (US$/Dose)
Table 15. Global Measles and Rubella Vaccines Sales by Company (2018-2023) & (K Doses)
Table 16. Global Measles and Rubella Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Measles and Rubella Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Measles and Rubella Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Measles and Rubella Vaccines Sale Price by Company (2018-2023) & (US$/Dose)
Table 20. Key Manufacturers Measles and Rubella Vaccines Producing Area Distribution and Sales Area
Table 21. Players Measles and Rubella Vaccines Products Offered
Table 22. Measles and Rubella Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Measles and Rubella Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Measles and Rubella Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Measles and Rubella Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Measles and Rubella Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Measles and Rubella Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Measles and Rubella Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Measles and Rubella Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Measles and Rubella Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Measles and Rubella Vaccines Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Measles and Rubella Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Measles and Rubella Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Measles and Rubella Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Measles and Rubella Vaccines Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Measles and Rubella Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Measles and Rubella Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Measles and Rubella Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Measles and Rubella Vaccines Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Measles and Rubella Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Measles and Rubella Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Measles and Rubella Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Measles and Rubella Vaccines Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Measles and Rubella Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Measles and Rubella Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Measles and Rubella Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Measles and Rubella Vaccines Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Measles and Rubella Vaccines Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Measles and Rubella Vaccines
Table 58. Key Market Challenges & Risks of Measles and Rubella Vaccines
Table 59. Key Industry Trends of Measles and Rubella Vaccines
Table 60. Measles and Rubella Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Measles and Rubella Vaccines Distributors List
Table 63. Measles and Rubella Vaccines Customer List
Table 64. Global Measles and Rubella Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Measles and Rubella Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Measles and Rubella Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Measles and Rubella Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Measles and Rubella Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Measles and Rubella Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Measles and Rubella Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Measles and Rubella Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Measles and Rubella Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Measles and Rubella Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Measles and Rubella Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Measles and Rubella Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Measles and Rubella Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Measles and Rubella Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Serum Institute of India Ltd. Basic Information, Measles and Rubella Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Serum Institute of India Ltd. Measles and Rubella Vaccines Product Portfolios and Specifications
Table 80. Serum Institute of India Ltd. Measles and Rubella Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 81. Serum Institute of India Ltd. Main Business
Table 82. Serum Institute of India Ltd. Latest Developments
Table 83. Merck & Co. Inc. Basic Information, Measles and Rubella Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck & Co. Inc. Measles and Rubella Vaccines Product Portfolios and Specifications
Table 85. Merck & Co. Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 86. Merck & Co. Inc. Main Business
Table 87. Merck & Co. Inc. Latest Developments
Table 88. GlaxoSmithKline Inc. Basic Information, Measles and Rubella Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Portfolios and Specifications
Table 90. GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 91. GlaxoSmithKline Inc. Main Business
Table 92. GlaxoSmithKline Inc. Latest Developments
Table 93. Takeda Pharmaceutical Company Basic Information, Measles and Rubella Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Portfolios and Specifications
Table 95. Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 96. Takeda Pharmaceutical Company Main Business
Table 97. Takeda Pharmaceutical Company Latest Developments
LIST OF FIGURES
Figure 1. Picture of Measles and Rubella Vaccines
Figure 2. Measles and Rubella Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measles and Rubella Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Measles and Rubella Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Measles and Rubella Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monovalent Vaccines
Figure 10. Product Picture of Multivalent Vaccines
Figure 11. Global Measles and Rubella Vaccines Sales Market Share by Type in 2022
Figure 12. Global Measles and Rubella Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Measles and Rubella Vaccines Consumed in Hospital
Figure 14. Global Measles and Rubella Vaccines Market: Hospital (2018-2023) & (K Doses)
Figure 15. Measles and Rubella Vaccines Consumed in Clinic
Figure 16. Global Measles and Rubella Vaccines Market: Clinic (2018-2023) & (K Doses)
Figure 17. Measles and Rubella Vaccines Consumed in Others
Figure 18. Global Measles and Rubella Vaccines Market: Others (2018-2023) & (K Doses)
Figure 19. Global Measles and Rubella Vaccines Sales Market Share by Application (2022)
Figure 20. Global Measles and Rubella Vaccines Revenue Market Share by Application in 2022
Figure 21. Measles and Rubella Vaccines Sales Market by Company in 2022 (K Doses)
Figure 22. Global Measles and Rubella Vaccines Sales Market Share by Company in 2022
Figure 23. Measles and Rubella Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Measles and Rubella Vaccines Revenue Market Share by Company in 2022
Figure 25. Global Measles and Rubella Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Measles and Rubella Vaccines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Measles and Rubella Vaccines Sales 2018-2023 (K Doses)
Figure 28. Americas Measles and Rubella Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Measles and Rubella Vaccines Sales 2018-2023 (K Doses)
Figure 30. APAC Measles and Rubella Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Measles and Rubella Vaccines Sales 2018-2023 (K Doses)
Figure 32. Europe Measles and Rubella Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Measles and Rubella Vaccines Sales 2018-2023 (K Doses)
Figure 34. Middle East & Africa Measles and Rubella Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Measles and Rubella Vaccines Sales Market Share by Country in 2022
Figure 36. Americas Measles and Rubella Vaccines Revenue Market Share by Country in 2022
Figure 37. Americas Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Figure 38. Americas Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Figure 39. United States Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Measles and Rubella Vaccines Sales Market Share by Region in 2022
Figure 44. APAC Measles and Rubella Vaccines Revenue Market Share by Regions in 2022
Figure 45. APAC Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Figure 46. APAC Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Figure 47. China Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Measles and Rubella Vaccines Sales Market Share by Country in 2022
Figure 55. Europe Measles and Rubella Vaccines Revenue Market Share by Country in 2022
Figure 56. Europe Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Figure 57. Europe Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Figure 58. Germany Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Measles and Rubella Vaccines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Measles and Rubella Vaccines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Measles and Rubella Vaccines in 2022
Figure 73. Manufacturing Process Analysis of Measles and Rubella Vaccines
Figure 74. Industry Chain Structure of Measles and Rubella Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Measles and Rubella Vaccines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Measles and Rubella Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Measles and Rubella Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Measles and Rubella Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Measles and Rubella Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Measles and Rubella Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Measles and Rubella Vaccines
Figure 2. Measles and Rubella Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measles and Rubella Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Measles and Rubella Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Measles and Rubella Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monovalent Vaccines
Figure 10. Product Picture of Multivalent Vaccines
Figure 11. Global Measles and Rubella Vaccines Sales Market Share by Type in 2022
Figure 12. Global Measles and Rubella Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Measles and Rubella Vaccines Consumed in Hospital
Figure 14. Global Measles and Rubella Vaccines Market: Hospital (2018-2023) & (K Doses)
Figure 15. Measles and Rubella Vaccines Consumed in Clinic
Figure 16. Global Measles and Rubella Vaccines Market: Clinic (2018-2023) & (K Doses)
Figure 17. Measles and Rubella Vaccines Consumed in Others
Figure 18. Global Measles and Rubella Vaccines Market: Others (2018-2023) & (K Doses)
Figure 19. Global Measles and Rubella Vaccines Sales Market Share by Application (2022)
Figure 20. Global Measles and Rubella Vaccines Revenue Market Share by Application in 2022
Figure 21. Measles and Rubella Vaccines Sales Market by Company in 2022 (K Doses)
Figure 22. Global Measles and Rubella Vaccines Sales Market Share by Company in 2022
Figure 23. Measles and Rubella Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Measles and Rubella Vaccines Revenue Market Share by Company in 2022
Figure 25. Global Measles and Rubella Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Measles and Rubella Vaccines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Measles and Rubella Vaccines Sales 2018-2023 (K Doses)
Figure 28. Americas Measles and Rubella Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Measles and Rubella Vaccines Sales 2018-2023 (K Doses)
Figure 30. APAC Measles and Rubella Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Measles and Rubella Vaccines Sales 2018-2023 (K Doses)
Figure 32. Europe Measles and Rubella Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Measles and Rubella Vaccines Sales 2018-2023 (K Doses)
Figure 34. Middle East & Africa Measles and Rubella Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Measles and Rubella Vaccines Sales Market Share by Country in 2022
Figure 36. Americas Measles and Rubella Vaccines Revenue Market Share by Country in 2022
Figure 37. Americas Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Figure 38. Americas Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Figure 39. United States Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Measles and Rubella Vaccines Sales Market Share by Region in 2022
Figure 44. APAC Measles and Rubella Vaccines Revenue Market Share by Regions in 2022
Figure 45. APAC Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Figure 46. APAC Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Figure 47. China Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Measles and Rubella Vaccines Sales Market Share by Country in 2022
Figure 55. Europe Measles and Rubella Vaccines Revenue Market Share by Country in 2022
Figure 56. Europe Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Figure 57. Europe Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Figure 58. Germany Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Measles and Rubella Vaccines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Measles and Rubella Vaccines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Measles and Rubella Vaccines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Measles and Rubella Vaccines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Measles and Rubella Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Measles and Rubella Vaccines in 2022
Figure 73. Manufacturing Process Analysis of Measles and Rubella Vaccines
Figure 74. Industry Chain Structure of Measles and Rubella Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Measles and Rubella Vaccines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Measles and Rubella Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Measles and Rubella Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Measles and Rubella Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Measles and Rubella Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Measles and Rubella Vaccines Revenue Market Share Forecast by Application (2024-2029)
